The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

Clinical trial NCT00243347 · COMPLETED

Trial details

NCT number: NCT00243347
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma Non-Small-Cell Lung Carcinoma Head and Neck Neoplasms

Start date: 2005-12-01
Primary completion: 2008-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.